Twice Too Many: Dilemma in Managing a Patient With Recurrent Near-death Events in Primary Care

Main Article Content

Fathima Begum Syed Mohideen
M. Radzniwan A. Rashid
Lim Mong Sai
Sharifah Najwa Syed Mohamad

Abstract

A 45-year-old man with diabetes, hypertension, dyslipidaemia, asthma, and gout presented after switching his oral anti-diabetes therapy from ertugliflozin to dapagliflozin, both SGLT2 inhibitors. Within a week, he suffered two anaphylactic attacks following urticarial episodes. Although allergic reactions to switching SGLT2 inhibitors are rare, the temporal relationship suggested a possible trigger. An allergy panel revealed high titres for house dust mites (HDM) and crab, prompting a review of his history. It was found that he had recently done spring cleaning and consumed seafood (crabs) before the anaphylaxis. This critical detail was missed in the initial consultation. After confirming the allergen sources, SGLT2 inhibitor therapy was safely resumed. The patient was advised to carry adrenaline auto-injectors for emergencies. This case underscores the need for greater awareness of IgE cross-reactivity among primary care doctors.

Downloads

Download data is not yet available.

Article Details

How to Cite
Syed Mohideen, F. B., A. Rashid, M. R., Sai, L. M., & Syed Mohamad, S. N. (2025). Twice Too Many: Dilemma in Managing a Patient With Recurrent Near-death Events in Primary Care. Malaysian Journal of Medicine and Health Sciences, 21(2), 285–288. https://doi.org/10.47836/mjmhs.21.2.37
Section
Case Report

References

Anaphylaxis. National Institute for Health and Clinical Excellence (NICE Clinical Guideline 134). December 2011 [updated 2021; cited 2021 Dec 27]. Available from: https://www.nice.org.uk/guidance/cg134/evidence/anaphylaxis-full-guideline-pdf-184946941

Yabe D, Nishikino R, Kaneko M, Iwasaki M, Seino Y. Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events. Expert Opin Drug Saf. 2015;14(6):795-800. DOI: 10.1517/14740338.2015.1034105

Hu Y, Bai Z, Tang Y, Liu R, Zhao B, Gong J, Mei D. Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a pharmacovigilance study with data from the U.S. FDA adverse event reporting system. J Diabetes Res.2020;2020:3695101.. DOI: 10.7759/cureus.27773

Lee YE, Im DS. SGLT2 Inhibitors Empagliflozin and Canagliflozin Ameliorate Allergic Asthma Responses in Mice. Int. J. Mol. Sci. 2024 Jul 10;25(14):7567. DOI: 10.3390/ijms25147567

Celi, G., Brusca, I., Scala, E., Villalta, D., Pastorello, E., Farioli, L., ... & Asero, R. (2020). House dust mite allergy and shrimp allergy: a complex interaction. European annals of allergy and clinical immunology, 52(5), 205-209. DOI: 10.23822/EurAnnACI.1764-1489.108